Evidence map›Paper›PMID 20472797›Full record

ArticleJournal of bacteriology2010

Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories.

Thomas R Ioerger, Yicheng Feng, Krishna Ganesula, Xiaohua Chen, Karen M Dobos, Sarah Fortune, William R Jacobs, Valerie Mizrahi, Tanya Parish, Eric Rubin and 2 more

Abstract read
In one paragraph

Article in Journal of bacteriology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

150 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Protein Architecture and Composition in Mycobacterium tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  6. Article
  7. Thienopyrimidine amide analogs target MmpL3 inAntimicrobial agents and chemotherapy · 2025
    Article
  8. Article
  9. Article
  10. Complete genome sequence of a virulent barcodedMicrobiology resource announcements · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Genomic Characterization of ISEvolutionary bioinformatics online · 2024
    Article
  17. The chosen few:Frontiers in immunology · 2024
    Review
  18. Article
  19. Article
  20. Article

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Thomas R IoergerDepartment of Computer Science and Engineering, Texas A&M University, College Station, TX 77843-3112, USA. ioerger@cs.tamu.edu
Yicheng Feng
Krishna Ganesula
Xiaohua Chen
Karen M Dobos
Sarah Fortune
William R Jacobs
Valerie Mizrahi
Tanya Parish
Eric Rubin
Chris Sassetti
James C Sacchettini

Funding

Tuberculosis Pathogenesis and Drug ResponseR01AI064282 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SASSETTI, CHRISTOPHER M · 2007 to 2017
$3.9M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI064282
6 · The paper itself

Abstract

The publication of the complete genome sequence for Mycobacterium tuberculosis H37Rv in 1998 has had a great impact on the research community. Nonetheless, it is suspected that genetic differences have arisen in stocks of H37Rv that are maintained in different laboratories. In order to assess the consistency of the genome sequences among H37Rv strains in use and the extent to which they have diverged from the original strain sequenced, we carried out whole-genome sequencing on six strains of H37Rv from different laboratories. Polymorphisms at 73 sites were observed, which were shared among the lab strains, though 72 of these were also shared with H37Ra and are likely to be due to sequencing errors in the original H37Rv reference sequence. An updated H37Rv genome sequence should be valuable to the tuberculosis research community as well as the broader microbial research community. In addition, several polymorphisms unique to individual strains and several shared polymorphisms were identified and shown to be consistent with the known provenance of these strains. Aside from nucleotide substitutions and insertion/deletions, multiple IS6110 transposition events were observed, supporting the theory that they play a significant role in plasticity of the M. tuberculosis genome. This genome-wide catalog of genetic differences can help explain any phenotypic differences that might be found, including a frameshift mutation in the mycocerosic acid synthase gene which causes two of the strains to be deficient in biosynthesis of the surface glycolipid phthiocerol dimycocerosate (PDIM). The resequencing of these six lab strains represents a fortuitous "in vitro evolution" experiment that demonstrates how the M. tuberculosis genome continues to evolve even in a controlled environment.

Indexed as

Genetic VariationGenome, BacterialBase SequenceDNA, BacterialLaboratoriesMycobacterium tuberculosisPhylogenyResearchDNA, Bacterial

Identifiers

PMID20472797
PMCPMC2897344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.